SCHEMBL95661

SCHEMBL95661

CCOC(=O)CCc1ccc(Cl)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.72
CYP4A11 Q02928 2/20 0.72
CYP4Z1 Q86W10 2/20 0.56
PLAAT3 P53816 1/20 0.53
PLAAT5 Q96KN8 1/20 0.53
PLAAT2 Q9NWW9 1/20 0.53
PLAAT4 Q9UL19 1/20 0.53
MAPT P10636 2/20 0.52
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 4/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
HRH3 Q9Y5N1 1/20 0.48
GAA P10253 2/20 0.47
CYP4F11 Q9HBI6 1/20 0.47
CYP4F12 Q9HCS2 1/20 0.47
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10736489 0.95 CYP4F2 (0.66) CYP4F2CYP4A11CYP4Z1PLAAT3PLAAT5
SCHEMBL10730919 0.92 CYP4F2 (0.62) CYP4F2CYP4A11CYP4Z1PLAAT3PLAAT5
SCHEMBL68902 0.91 CYP4F2 (0.85) CYP4F2CYP4A11CYP4Z1MAPTTDP1
SCHEMBL4467166 0.90 CYP4F2 (0.58) CYP4F2CYP4A11CYP4Z1PLAAT3PLAAT5
SCHEMBL17590526 0.88 CYP4Z1 (0.59) CYP4F2CYP4A11CYP4Z1PLAAT3PLAAT5
SCHEMBL11243173 0.87 MAPT (0.74) CYP4F2CYP4A11CYP4Z1PLAAT3PLAAT5
SCHEMBL11566476 0.87 CYP4F2 (0.56) CYP4F2CYP4A11MAPTLMNAKMT2A
SCHEMBL11564286 0.87 CYP4F2 (0.56) CYP4F2CYP4A11MAPTLMNAKMT2A
SCHEMBL11039828 0.87 CYP4Z1 (0.58) CYP4F2CYP4A11CYP4Z1MAPTTDP1
SCHEMBL3678807 0.87 CYP4F2 (0.55) CYP4F2CYP4A11CYP4Z1PLAAT3PLAAT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116640104-B Industrial synthesis method of telithromycin 杭州科耀医药科技有限公司 2024-04-02 CN claimed
CN-116640104-A Industrial synthesis method of telithromycin 杭州科耀医药科技有限公司 2023-08-25 CN claimed
CN-116640104-B Industrial synthesis method of telithromycin 杭州科耀医药科技有限公司 2024-04-02 CN disclosed
CN-116640104-A Industrial synthesis method of telithromycin 杭州科耀医药科技有限公司 2023-08-25 CN disclosed
CN-115572252-A Isoindolinone inhibitors of MDM2-P53 interaction with anti-cancer activity 阿斯泰克斯治疗有限公司 2023-01-06 CN disclosed
CN-110330429-A A kind of preparation method of chiral beta-hydroxy ester compound 上海欣海国际贸易有限公司 2019-10-15 CN disclosed
CN-110003005-A The method for preparing chiral beta-hydroxy carboxylate compound 上海欣海国际贸易有限公司 2019-07-12 CN disclosed
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-4472380-A CARBOXYALKYL DIPEPTIDE DERIVATIVES MERCK & CO., INC. (US) 1984-09-18 US disclosed
US-4374829-A Aminoacid derivatives as antihypertensives MERCK & CO., INC. (US) 1983-02-22 US disclosed
US-4243683-A INSECTICIDES, MITICIDES MAY & BAKER LIMITED (GB) 1981-01-06 US disclosed
EP-0012401-A1 Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them MERCK & CO. INC. (US) 1980-06-25 EP disclosed
US-4138577-A 11-Deoxy-cis-4,5-didehydro-ω-aryl-PGF compounds THE UPJOHN COMPANY (US) 1979-02-06 US disclosed
US-4138573-A 11-Deoxy-2,2-difluoro-ω-aryl-PGE compounds THE UPJOHN COMPANY (US) 1979-02-06 US disclosed
US-4138575-A 11-Deoxy-16-phenoxy-PGF compounds THE UPJOHN COMPANY (US) 1979-02-06 US disclosed
US-4138576-A 11-Deoxy-2,2-difluoro-ω-aryl-PGF compounds THE UPJOHN COMPANY (US) 1979-02-06 US disclosed
US-4126754-A 11-Deoxy-cis-4,5-didehydro-ω-aryl-PGE compounds THE UPJOHN COMPANY (US) 1978-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 CYP4F2 82/4885CYP4A11 818/4885CYP4Z1 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.